BioTuesdays

Category - News

Tear Film Logo
Developments

Tear Film Innovations closes Series B financing

Closely-held Tear Film Innovations completed an $8.5-million Series B preferred stock round led by Visionary Ventures Fund and Bluestem Capital. “This successful funding round completes the capitalization for our growth...

May 22, 2018
Synthetic Biologics Logo
Markets

HCW starts Synthetic Biologics at buy; PT $1

H.C. Wainwright initiated coverage of Synthetic Biologics (NYSE AMERICAN:SYN) with a “buy” rating and price target of $1. The stock finished at 25 cents on May 17. Analyst Edward White writes that the new coverage is...

May 21, 2018
Agile Therapeutics
Markets

HCW halves Agile Therapeutics PT to $4

H.C. Wainwright halved its price target for Agile Therapeutics (NASDAQ:AGRX) to $4 from $8 after the company updated the regulatory status of Twirla, its weekly transdermal contraceptive patch. The stock closed at 69...

May 21, 2018
Helius Medical Technologies Logo
Markets

BTIG starts Helius Medical at buy; PT $14

BTIG initiated coverage of Helius Medical Technologies (NASDAQ:HSDT) with a “buy” rating and $14 price target. The stock closed at $11.11 on May 16. “Helius has the potential to help people with traumatic brain injuries...

May 17, 2018
Anavex
Markets

Maxim ups Anavex Life Sciences PT to $7

Maxim Group raised its price target for Anavex Life Sciences (NASDAQ:AVXL) to $7 from $5, after factoring in Anavex 2-73 for additional indications: Rett syndrome and Parkinson’s disease, beyond Alzheimer’s disease. The...

May 16, 2018
Markets

Roth starts Daré Bioscience at buy; PT $6

Roth Capital Partners initiated coverage of Daré Bioscience (NASDAQ:DARE) with a “buy” rating and $6 price target. The stock closed at $1.07 on May 15. Daré brings innovation to the contraception market, writes analyst...

May 16, 2018